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Large parts of sub-Saharan Africa have effectively
no health care at all, with only 600 000 healthcare
workers for a population of 682 million.2 For example
in Ghana, faced with a ratio of nine doctors to every
100 000 patients,3 is it any wonder that young, talented
health professionals are burnt out and despairing, and
that they leave for a better life in the North? Only 60 of
the 500 doctors trained in Zambia since independence
are still there.4 Mozambique has only 500 doctors for a
population of 18 million.5
What can be done? We cannot and should not pre-
vent completely the migration of doctors and nurses.
Medicine has a strong tradition of international
collaboration, with doctors moving around the globe
to gain further training and different clinical
experience. Indeed, we like to think that international
exchange and diversity enrich us all. This is a romantic
delusion. We gain in the North, but developing
countries lose out by losing their doctors permanently.
Any number of incentives have been tried to
persuade doctors to remain in or return to their coun-
tries of origin—enhanced salaries, better pensions, cars,
and housing allowances. Ethical recruitment codes
may make us feel that we occupy the moral high
ground. But, as long as the rich countries have plenty
of vacancies, the flow of healthcare professionals from
South to North will continue.
The most important element of the solution is self
sufficiency. The BMA and the Royal College of Nursing
have urged the prime minister and the chancellor of the
exchequer to commit the UK to training enough
people to become self sufficient in workforces of
doctors and nurses. This would not be a huge leap for
the UK since we have been expanding the number of
medical school places year on year since 1997.Over the
same period, we could radically expand the number of
exchanges, overseas elective periods, and twinning
programmes that would help our very hard pressed
colleagues to feel less isolated and overburdened.
But what of the US? Already, it employs half of all
English speaking doctors in the world. And it wants
more. By deadly coincidence, the US wants to employ
one million more healthcare workers in the next 15
years6—exactly the extra number needed for sub-
Saharan Africa to fulfil the millennium development
goals.7 The US system regards healthcare professionals
as a commodity to be purchased in the market and is
making little provision currently to increase the
number of doctors and nurses it trains at home. Nurses
in the US, with an average salary of $65 000 (£36 000;
€53 000),8 are the most highly paid in the world.
The US is a great place to live and work. Unless it
can be persuaded to think and act differently, it will
soak up skilled workforce from every available source,
including the UK. We would find it difficult and
irksome to spend UK taxpayers’ money training
doctors to care for American patients. But we are a rich
country, and many of those doctors would eventually
return home. Ghana is already contributing to an
obscene reversal of the flow of aid: it spends around
$9m each year on medical education9 only to lose its
doctors to a voracious and insatiable health market in
the North. The African initiative of the G8 countries
will fail spectacularly if the richest nations of the world
do not allow the poorest to maintain the bare essentials
of healthcare provision.
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Do white British children and adolescents get
enough sunlight?
Probably, and calls to abandon campaigns for skin cancer awareness are misguided
Fear of skin cancer, prompted by campaigns suchas “SunSmart” (www.sunsmart.org.uk) in theUnited Kingdom, may have led to children
spending less time exposed to sunlight, reducing
opportunities for the production of vitamin D in the
skin and resulting in a consequent detriment to bone
health.1 Furthermore, recent evidence shows that sun-
light exposure and the resulting synthesis of vitamin D
might reduce the risk of certain cancers2 and, perhaps,
of other diseases such as multiple sclerosis.3 In
response, there have been calls for current skin cancer
awareness campaigns in the UK to be abandoned.4 Are
such calls justified?
Adequate sun exposure is not easily defined,1 but
one of the leading proponents of the beneficial effects of
sun exposure has indicated that exposing the face,
hands and arms two to three times a week to a third to a
half of the exposure necessary to result in a just percep-
tible reddening of white skin (the so called minimal ery-
thema dose,MED) in the spring, summer, and autumn is
more than adequate to satisfy the body’s requirement for
vitamin D throughout the year.5 In other words,
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receiving a weekly dose of around 1 MED to these sites
should be sufficient to prevent vitamin D insufficiency. If
only the face and hands are normally exposed, then a
weekly dose of about 2 MED would be required.
In 1994 we measured the sun exposure of 180
children and adolescents in three regions of England
during the spring and summer and found that 98.5%
and 91% of children and adolescents, respectively,
exceeded a weekly dose of 1 MED.6 Adolescents,
however, and especially teenage boys, generally expose
only their hands and face when outside: the prevalence
of weekly doses that exceeded 2 MED in this age group
was only 58%. The median time spent outdoors each
day by adolescents during those periods when the
weekly dose was less than 2 MED was 1.6 hours, rising
to 2.5 hours when the weekly dose exceeded 2 MED.
A popular perception is that being outdoors for
5-10 minutes, two or three times a week, in the summer
is sufficient for effective vitamin D production. The
reason why one to two hours outdoors each day was
insufficient in many cases to result in a cumulative
weekly dose of 2 MED, even though in the summer this
dose could be achieved by lying in unshaded sunshine
for about half an hour around noon, is that people are
generally upright, the sky is often cloudy in the UK and
buildings and trees often obscure direct sunlight and
part of the sky. All these factors serve to reduce the
intensity of sunlight on exposed skin thus necessitating
the need for prolonged exposure to acquire sufficient
dose. That the exposure to sunlight in many
adolescents may be insufficient in the spring and sum-
mer would certainly account for the observations that
the wintertime vitamin D status of almost all teenage
girls living in northern Europe is insufficient.7 The
association between low vitamin D levels in young
people and the subsequent risk of diseases such as
osteoporosis or cancer is not clear, however, so the
wider implications of this are uncertain.3 7
Such evidence that many adolescents are not suffi-
ciently exposed to the sun is not enough to justify
abandoning current awareness campaigns about skin
cancer, which are aimed primarily at avoiding excessive
exposure. This is especially true for children and
adolescents, for whom exposure to high levels of
sunlight strongly determines subsequently increased
risk of melanoma.8 This is a disease whose incidence is
predicted to continue rising in the UK for at least
another 30 years, even if current intervention strategies
eventually translate into a downturn in incidence.9
Furthermore, campaigns such as SunSmart are
intended to advise people primarily during recrea-
tional exposure for extended periods in strong
sunshine when measures to protect the skin, even if
they are used, will not be perfect and will still allow the
synthesis of vitamin D.10 So such campaigns should not
be abandoned, and British children and adolescents
need not deliberately spend extended periods in
strong sunshine. Rather, those whose lives are spent
almost entirely indoors, in the shade, or in vehicles
should take the opportunity during casual everyday
activities to walk on the sunny side of the street and,
when possible, to avoid taking the car.
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Drug safety and regulation
New powers and resources are needed
In the past few months, medical journals havepublished numerous editorials and news itemsrelating to drug safety and regulation.1–3 The
withdrawal of rofecoxib (Vioxx) has been the single big-
gest issue,4 but the cardiovascular safety of other
cyclo-oxygenase-2 (COX 2) inhibitors5 and possible sui-
cidal tendencies associated with selective serotonin
reuptake inhibitor (SSRI) antidepressants have also
raised considerable concerns.6 These high profile cases
have resulted in the regulatory bodies responsible for
drug safety coming under fire.
From reports in journals it would be easy to get the
impression that the US Food and Drug Administration
was uniquely at fault over the regulation of COX 2
inhibitors7 and the UK Medicines and Healthcare
products Regulatory Agency over paroxetine.3 Given
that the regulatory decisions made before and after the
marketing of these drugs have been similar throughout
the developed world, this can hardly be a logical
conclusion. Overall, regulators around the world use
similar systems and make similar decisions. If they all
get something wrong then it is probably the fault of
inadequacies in the underlying systems and, perhaps,
the science underpinning them.
We have been, and are, involved with drug
regulation in the United Kingdom. We believe that the
whole safety system for drugs might be improved,
going well beyond the processes of regulation itself.
For example, the pharmaceutical industry clearly has
an important role, although the extent and nature of its
influence have recently been called into question.8 It is
important to keep a perspective on where the existing
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